Burning Rock Biotech (BNR) Total Liabilities (2021 - 2023)

Burning Rock Biotech has reported Total Liabilities over the past 3 years, most recently at $37.7 million for Q4 2023.

  • Quarterly results put Total Liabilities at $37.7 million for Q4 2023, down 37.48% from a year ago — trailing twelve months through Dec 2023 was $37.7 million (down 37.48% YoY), and the annual figure for FY2023 was $38.3 million, down 40.15%.
  • Total Liabilities for Q4 2023 was $37.7 million at Burning Rock Biotech, down from $60.3 million in the prior quarter.
  • Over the last five years, Total Liabilities for BNR hit a ceiling of $67.8 million in Q4 2021 and a floor of $37.7 million in Q4 2023.
  • Median Total Liabilities over the past 3 years was $60.3 million (2022), compared with a mean of $55.3 million.
  • Biggest five-year swings in Total Liabilities: fell 10.97% in 2022 and later crashed 37.48% in 2023.
  • Burning Rock Biotech's Total Liabilities stood at $67.8 million in 2021, then decreased by 10.97% to $60.3 million in 2022, then crashed by 37.48% to $37.7 million in 2023.
  • The last three reported values for Total Liabilities were $37.7 million (Q4 2023), $60.3 million (Q4 2022), and $67.8 million (Q4 2021) per Business Quant data.